UAB Department of Neurology

08/28/2026

Congratulations to Victor Del Bene, Ph.D.; Jerzy Szaflarski, M.D., Ph.D.; Erik Roberson, M.D., Ph.D.; and their team led by Virendra Mishra, Ph.D., in the Department of Radiology, for being one of the eight inaugural teams selected for the UAB Heersink School of Medicine Team Science Grant Program.

Learn more about the eight inaugural teams: https://buff.ly/o5aRDx6

08/27/2026

Erik D. Roberson, M.D., Ph.D., is leading research at the UAB Heersink School of Medicine Department of Neurology with Shreya Kashyap, M.D., Ph.D., and Stephanie Fox, Ph.D., that could help improve gene therapy for frontotemporal dementia (FTD).

The team found that modifying the progranulin protein improved the therapy’s effectiveness in a mouse model of FTD.

Read more about the study and its potential implications for future FTD treatments: https://buff.ly/rrDqnsF

08/25/2026

The Alabama Academy of Neurology 2026 Conference is this weekend at the Grand Bohemian Hotel in Mountain Brook with these faculty members of the UAB Heersink School of Medicine Department of Neurology presenting!

Learn more: https://buff.ly/kmQeGqm

08/24/2026

How many faces do you recognize? This faculty photo from 2005 features a mix of both current faculty and alumni who have gone on to other endeavors. We celebrate the longevity of those who are still here and remember our faculty alumni fondly!

08/20/2026

The American Parkinson Disease Association at UAB will host a session for patients diagnosed with Parkinson's Disease within three years. Participants will receive educational information about Parkinson's, learn how to build a care team, and be provided with local Parkinson's support services. A care partner is encouraged to join. UAB Medicine

Register: https://buff.ly/9oQ2B9y

08/19/2026

Members of the department had a great time at Mitchell's Place, Inc. Dragon Boat Race & Festival!

It was a fun day of teamwork and community while supporting Mitchell’s Place raising awareness for early intervention and autism spectrum disorder.

UAB Heersink School of Medicine

08/18/2026

UAB is conducting research to study bleeding in the brain, also called intracerebral hemorrhage (ICH). Most of this bleeding occurs within a few hours of onset of symptoms. The brain injury from ICH is usually very severe, and there is currently no treatment for ICH that is proven to improve outcome.

The FASTEST research study is being done to determine if a protein (rFVIIa) that our body makes to stop bleeding at the site of injury to a blood vessel, can slow bleeding in the brain and improve outcome. Participants in the FASTEST research study are placed at random, that is by chance, into one of 2 groups. They have an equal chance of getting rFVIIa or placebo (no active ingredient). Some patients will be enrolled without consent if a family member or representative is not rapidly available.

Before the research study starts, we will consult with the community. We welcome your feedback and questions. For more information, or to decline participation in this research study, please contact our study staff at 205-975-8569. EFIC online survey: https://redcap.research.cchmc.org/surveys/ Enter this code: LWP9YE97Y

08/13/2026

Nita Limdi, Pharm.D., Ph.D., MSPH, was featured in the Alabama Political Reporter discussing her NIH award to expand genomic screening in primary care. Congratulations, Dr. Limdi! 👏
UAB Heersink School of Medicine

Read more: https://buff.ly/WaZNI2E

08/06/2026

Please join us for the next Neurology Research Education Series on Aug. 26 at noon! The topic is "Informed Consent, Re-Consenting, & Capacity to Consent." Kindly register by Aug. 19: https://buff.ly/lMWAZYk

07/30/2026

Congratulations to Nita Limdi, Pharm.D., Ph.D., MSPH, on helping lead a new NIH-funded Population Genomic Screening Network initiative to advance genomic screening in primary care.

Learn more: https://buff.ly/swyXnwy

UAB Heersink School of Medicine | UAB Medicine | UAB - The University of Alabama at Birmingham

UAB will help lead an NIH-funded Population Genomic Screening Network initiative to integrate genomic screening into primary care, enabling earlier detection of inherited cancer, cardiovascular and other genetic risks to improve prevention, health outcomes and equitable care.